| 股票代码 | 股票名称 | 持有份额(万股) | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 0.0000 | 6.30% | -1.41% | -0.0888% |
| 01801 | 信达生物 | 0.0000 | 4.95% | -0.45% | -0.0223% |
| 000423 | 东阿阿胶 | 0.0000 | 3.28% | -0.53% | -0.0174% |
| 00013 | 和黄医药 | 0.0000 | 3.22% | 1.91% | 0.0615% |
| 300347 | 泰格医药 | 0.0000 | 3.00% | 1.29% | 0.0387% |
| 600422 | 昆药集团 | 0.0000 | 2.77% | 0.74% | 0.0205% |
| 688212 | 澳华内镜 | 0.0000 | 2.66% | -0.88% | -0.0234% |
| 603259 | 药明康德 | 0.0000 | 2.48% | 1.12% | 0.0278% |
| 688266 | 泽璟制药-U | 0.0000 | 2.48% | -2.71% | -0.0672% |
| 688235 | 百济神州-U | 0.0000 | 1.75% | 1.16% | 0.0203% |
| 重仓股仓位合计 | 重仓股贡献增长率 | 总持股仓位 | 修正增长率 | ||
| 32.89% | -0.0503% | 84.50% | |||
| 日期 | 实际增长率 | 预估增长率 |
| 2025-01-27 | -0.01% | 0.26% |
| 2025-01-22 | -0.50% | -0.59% |
| 2025-01-14 | 2.42% | 1.94% |
| 2025-01-13 | 0.64% | 0.43% |
| 2025-01-10 | -0.81% | -1.04% |
| 2025-01-09 | -0.19% | -0.11% |
| 2025-01-08 | -1.15% | -1.00% |
| 2025-01-07 | -1.02% | -0.68% |
| 基金名称 | 单位净值 | 日增长率 |
| 国投瑞银创新医疗混合 | 0.8129 | 1.1648% |
| 国投瑞银竞争优势混合A | 0.7103 | 0.6328% |
| 国投瑞银竞争优势混合C | 0.6982 | 0.6328% |
| 国投成长 | 0.4774 | 0.6300% |
| 国投创新 | 0.4245 | 0.6159% |
| 国投瑞银价值成长一年持有混合A | 0.6581 | 0.6010% |
| 国投瑞银价值成长一年持有混合C | 0.6478 | 0.6010% |
| 国投医疗保健 | 0.8239 | 0.5630% |
